NDC 71205-667 – Oxybutynin chloride
Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · Oral
Product NDC71205-667
Product details
- Brand name
- Oxybutynin chloride
- Generic name
- Oxybutynin chloride
- Labeler
- Proficient Rx LP
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA207138
- Marketed since
- December 20, 2016
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Active ingredients
- Oxybutynin Chloride 10 mg/1
Uses, dosage, side effects and warnings for Oxybutynin Chloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 71205-667-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-667-30) | Jun 8, 2022 |
| 71205-667-60 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-667-60) | Jun 8, 2022 |
| 71205-667-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71205-667-90) | Jun 8, 2022 |
Other Oxybutynin Chloride products
- 50090-6840 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-6673 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-5822 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 50090-4307 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · A-S Medication Solutions
- 16729-317 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · Accord Healthcare, Inc.
- 16729-318 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · Accord Healthcare, Inc.
- 16729-319 Oxybutynin Chloride 15 mg/1 · Tablet, Extended Release · Accord Healthcare, Inc.
- 72888-030 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-032 Oxybutynin Chloride 15 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 72888-031 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · Advagen Pharma Limited
- 27241-155 Oxybutynin Chloride 5 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.
- 27241-156 Oxybutynin Chloride 10 mg/1 · Tablet, Extended Release · Ajanta Pharma USA Inc.